Key takeaways:
Breo Ellipta (fluticasone/vilanterol) and Advair (fluticasone/salmeterol) inhalers treat asthma and chronic obstructive pulmonary disease (COPD). A major difference between them is that Breo Ellipta is used once a day and Advair is used twice a day.
Breo Ellipta is a dry powder inhaler (DPI). Advair comes as a DPI, called Advair Diskus, and a metered dose inhaler (MDI) called Advair HFA. DPIs require you to breathe the medication into your lungs quickly and forcefully. With MDIs, you breathe the medication in more slowly and hold your breath.
Breo Ellipta and Advair Diskus are both also available as lower-cost generics. GoodRx can help you save over 60% off the average retail price at certain pharmacies.
If you have asthma, you may have been prescribed a couple of different inhalers. These medications can help reduce daily asthma symptoms, preventing future asthma attacks, and preventing long-term lung damage.
With so many inhalers on the market, it can be confusing to know which one is best for you. We’ll compare two of the most common long-acting maintenance inhalers: Breo Ellipta (fluticasone/vilanterol) and Advair (fluticasone/salmeterol). Both of these inhalers help prevent asthma attacks and decrease daily symptoms.
Both Breo Ellipta and Advair are prescription inhalers that treat asthma. Breo Elipta and one type of Advair inhaler — Advair Diskus — are also approved for chronic obstructive pulmonary disease (COPD).
These inhalers are different from quick-relief (or rescue) inhalers, which kick in within minutes and are used as needed for asthma attacks. Breo Ellipta and Advair cannot be used to treat acute flare-ups of asthma or COPD. These long-acting maintenance inhalers are used daily, even if you have no symptoms.
Breo Ellipta and Advair are combination inhalers that contain two medications that work together to improve airflow:
An inhaled corticosteroid (ICS) to improve inflammation in the airway
A long-acting beta-agonist (LABA) to keep the airways relaxed and open
Both Breo Ellipta and Advair contain the corticosteroid fluticasone. The LABA in Breo Ellipta is vilanterol, and the LABA in Advair is salmeterol. Of note, there are other fluticasone/salmeterol inhalers available on the market, including AirDuo Digihaler and AirDuo Respiclick.
Breo Ellipta is approved to treat adults only. Advair Diskus is approved for both adults and children aged 4 years and older. Advair HFA is approved for adults and children who are at least 12 years old.
The Global Initiative for Asthma guidelines consider Breo Ellipta and Advair to be similarly effective at treating moderate-to-severe asthma. And the Global Initiative for Chronic Obstructive Lung Disease guidelines also consider Breo Ellipta and Advair to be similarly effective at treating moderate-to-very severe COPD. In short, neither guideline recommends one inhaler over the other.
Still, it’s good to examine the research when you’re comparing two medications. There have been a few randomized control trials (RCTs) — the best studies for identifying cause and effect — looking at Breo Ellipta versus Advair. One that included over 1,000 people with asthma found that Breo Ellipta and Advair were similarly effective at improving lung function. The study also found that the inhalers had similar side effects.
The available RCTs on Breo Ellipta versus Advair for COPD have shown that they’re similarly effective at treating the condition.
One important difference between the inhalers is that Breo Ellipta is a once-daily medication and Advair is used twice daily (12 hours apart). The type of fluticasone in Breo Ellipta (fluticasone furoate) is thought to last longer than the type of fluticasone in Advair (fluticasone propionate).
The medications also come in different doses:
Breo Ellipta: 100 mcg or 200 mcg fluticasone furoate with 25 mcg vilanterol
Advair Diskus: 100 mcg, 250 mcg, or 500 mcg fluticasone propionate with 50 mcg salmeterol
Advair HFA: 45 mcg, 115 mcg, or 230 mcg fluticasone propionate with 21 mcg salmeterol
Another important difference between Breo Ellipta and Advair is that Advair comes in two forms:
Dry powder inhaler (DPI): Advair Diskus and Breo Ellipta
Metered dose inhaler (MDI): Advair HFA
Breo Ellipta only comes as a DPI. With DPIs, you inhale a dose of powdered medication into your lungs. The medication is released only when you take a deep, fast breath through the inhaler. This is different from an MDI, which pushes the medication into your lungs using an aerosol spray. With an MDI, you inhale the medication slowly over 3 to 5 seconds, then you hold your breath for 10 seconds if possible before exhaling.
Because both Breo Ellipta and Advair contain a corticosteroid and a LABA, the side effects are similar. Common side effects of these inhalers include:
Upper respiratory tract infections, such as the common cold
Fungal infections of the mouth and throat, such as thrush
Hoarseness and voice changes
Headache
Dizziness
Although rare, more serious side effects can also happen with Breo Ellipta and Advair, including:
Increased potassium and blood sugar levels: Your healthcare provider may have you go for blood tests from time to time to monitor for these changes.
More serious lung infections: This includes lower respiratory tract infections, like pneumonia.
Greater risk for other infections: This is especially true if you have a weakened immune system.
Heart problems: This could include blood pressure changes, a faster heart rate, or an abnormal heartbeat. If you have an existing heart problem, like an arrhythmia or high blood pressure (hypertension), let your healthcare provider know.
Weaker bones in adults and slowed growth in children: These are possible side effects of oral corticosteroids. They’re probably less likely with inhaled corticosteroids, but your provider will still monitor for these changes.
Eye problems: This could include glaucoma, cataracts, or dry eye. You may need regular eye exams while using one of these inhalers. If you develop any vision changes, let your provider know right away.
Paradoxical bronchospasm: This unexpected tightening of the airways makes breathing difficult and requires immediate use of a rescue inhaler, like albuterol (ProAir HFA, Proventil HFA, Ventolin HFA). If you don’t have a rescue inhaler available, call 911 or go to your nearest emergency room.
Here is a list of common medications that may interact with Breo Ellipta or Advair:
Beta blockers like metoprolol (Lopressor) and carvedilol (Coreg)
Medications that can cause abnormal heart rhythm by prolonging the “QT interval,” including tricyclic antidepressants and monoamine oxidase inhibitors
Some antifungals, like ketoconazole
Some HIV medications, like those containing ritonavir (Norvir) or atazanavir (Reyataz)
This list is not comprehensive. Talk with your healthcare provider and pharmacist before starting treatment with an inhaler. They can help you check for medication interactions and adjust the doses of your other medications if needed. But you may only need more frequent monitoring with blood tests.
Keep in mind: DPIs like Breo Ellipta and Advair Diskus may contain lactose, a sugar found in cow’s milk. So people with a severe milk protein allergy should avoid these inhalers. Advair HFA doesn’t contain lactose, so it may be a good alternative.
There are many ways to save on the brand-name and generic versions of Breo Ellipta and Advair.
GoodRx may be able to help you save over 60% off the average retail price of the generic version of Breo Ellipta. Generic Breo Ellipta’s price at certain pharmacies may be as low as $233.52 with a free GoodRx coupon.
You can also save on brand-name Breo Ellipta through patient assistance programs. If you’re uninsured or have Medicare, you may be eligible for Breo Ellipta’s patient assistance program, which offers the medication free of cost.
GoodRx may be able to help you save over 70% off the average retail price of the two generic versions of Advair Diskus. Fluticasone/salmeterol’s price at certain pharmacies may be as low as $56.66 with a free GoodRx coupon. Wixela Inhub's price may be as low as $56.66 with a free GoodRx coupon.
You can also save on brand-name Advair Diskus or Advair HFA through patient assistance programs. If you’re uninsured or have Medicare, you may be eligible for Advair’s patient assistance program, which offers the medication free of cost.
As mentioned, Breo Ellipta and Advair contain a corticosteroid and a LABA. Some alternatives to Breo Ellipta and Advair that also contain these two types of medications include:
Symbicort is available as a generic medication (Breyna), but Dulera is brand-name only. They’re both MDIs that are used twice daily (like Advair HFA). Generic Symbicort might be a good alternative to brand-name Advair HFA if you want a lower-cost MDI. But you can also use GoodRx to access Dulera at an exclusive cash price of $199.
Fluticasone (Flovent Diskus, Flovent HFA) and salmeterol (Serevent Diskus) are also available on their own as single-medication inhalers. But using two inhalers is likely more expensive than using a combination inhaler.
Breo Ellipta (fluticasone/vilanterol) and Advair (fluticasone/salmeterol) are long-term maintenance inhalers. They contain two types of medications: a corticosteroid and a long-acting beta-agonist (LABA). Breo Ellipta, Advair Diskus, and Advair HFA are used for asthma treatment. And Breo Ellipta and Advair Diskus can also be used to treat chronic obstructive pulmonary disease (COPD).
Breo Ellipta is used once a day while Advair inhalers are used twice a day. These inhalers can cause similar side effects, including the common cold, oral thrush, and voice changes. More serious side effects include severe lung infections, heart problems, and eye problems.
Breo Ellipta and Advair Diskus are available as lower-cost generics. But Advair HFA is only available as a brand-name medication.
A-S Medication Solutions. (2021). Advair Diskus [package insert].
Agusti, A., et al. (2014). A comparison of the efficacy and safety of once-daily fluticasone furoate/vilanterol with twice-daily fluticasone propionate/salmeterol in moderate to very severe COPD. European Respiratory Review.
Barnes, P. J. (2010). Inhaled corticosteroids. Pharmaceuticals.
Bernstein, D., et al. (2017). Once-daily fluticasone furoate/vilanterol versus twice-daily fluticasone propionate/salmeterol in patients with asthma well controlled on ICS/LABA. Journal of Asthma.
Biggadike, K. (2011). Fluticasone furoate/fluticasone propionate – Different drugs with different properties. The Clinical Respiratory Journal.
Dransfield, M. T., et al. (2014). Efficacy and safety of once-daily fluticasone furoate/vilanterol (100/25 mcg) versus twice-daily fluticasone propionate/salmeterol (250/50 mcg) in COPD patients. Respiratory Medicine.
GlaxoSmithKline LLC. (2021). Advair HFA [package insert].
GlaxoSmithKline LLC. (2021). Breo Ellipta [package insert].
Global Initiative for Asthma. (2022). Global strategy for asthma management and prevention, 2022.
Global Initiative for Chronic Obstructive Lung Disease. (2023). Pocket guide to COPD diagnosis, management, and prevention: A guide for health care professionals.
Miravitlles, M., et al. (2021). Systematic review on long-term adverse effects of inhaled corticosteroids in the treatment of COPD. European Respiratory Review.
Philip, J. (2014). The effects of inhaled corticosteroids on growth in children. The Open Respiratory Medicine Journal.